Víctor Manuel Infante Viñolo

Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain.

Biobide is a biotechnology company focused on automated High Throughput Screening (HTS) of potential new drugs. Its goal is to introduce a different service-screening concept into the market by using the zebrafish (Danio rerio) as a model organism. Biobide was founded in June 2005 in order to resolve the main problem acing that contemporary biotechnological and pharmaceutical companies were facing: how to deal with the low success rate in marketing new drugs. Biobide offers a marked improvement in the success rate of new drug research and development through its own quick, efficient and reliable screening system, providing substantially more / better information about potential drugs.

Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain.

Bioorganic Research & Services SA engages in the research and development of biopharmaceutical products for the veterinarian sector. Its portfolio includes vaccines, recombinant proteins and antibodies. The company was founded on March 1, 2005 and is headquartered in Cádiz, Spain.